Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
progression, with the ultimate aim to develop innovative nucleic acid therapeutics against cancer. We make use of advanced molecular and cellular technologies to identify novel targets and get insight
-
Company description The Virology, Antiviral & Vaccine Research group at the Rega Institute, led by Prof. Johan Neyts, plays a leading role in the development of innovative antiviral strategies
-
effector functions. Such understanding is essential for the development of new therapies against cancer and infectious diseases. Further information on our work can be found on our homepage and in our
-
young, dynamic, and interdisciplinary research team Access to state-of-the-art imaging technologies and preclinical research facilities A wide range of training, mentoring, and career development
-
outgrowth assays • Investigate HIV integration sites in relation to p24 expression • Collaborate closely with national partners within the DZIF network • Prepare data for publications and
-
, and state-of-the-art infrastructure. Our model empowers visionary leaders to accelerate drug development and harness AI-driven innovation to address unmet medical needs. Benefits of Working with Great
-
contribute to the development of the Institute’s academic programs, mainly aimed at master's students, but also for bachelor's degrees, on-the-job training and MOOCs. The applicant will participate in
-
sciences and artificial intelligence, and translate your findings to improve human health? Are you excited to develop and use machine learning approaches to gain new understanding of the molecular physiology
-
team! Your personal sphere of influence: The Konrat lab is developing NMR spectroscopy methods for structural cell biology and is looking for a PhD student to join the team. The employment duration is 3
-
, ideally with knowledge of Drosophila genetics and live imaging the applicant should be able to relocate for 6 months to our collaborator in Chile, where they will develop and optimize novel metabolite